Mallinckrodt (NYSE: MNK) will pay a premium of approximately $1.3 billion to acquire Cadence Pharmaceuticals Inc. (Nasdaq: CADX). Shares of Cadence leaped $2.93 to $14.00 while Mallinckrodt stock jumped $6.75 to $66.06.
Mallinckrodt To Buy Cadence Pharmaceuticals
February 11, 2014 at 12:13 PM EST
